US746749A - Nasal medicator. - Google Patents

Nasal medicator. Download PDF

Info

Publication number
US746749A
US746749A US14828403A US1903148284A US746749A US 746749 A US746749 A US 746749A US 14828403 A US14828403 A US 14828403A US 1903148284 A US1903148284 A US 1903148284A US 746749 A US746749 A US 746749A
Authority
US
United States
Prior art keywords
nasal
fitting
medicator
receptacle
construction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US14828403A
Inventor
George E Seidel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US14828403A priority Critical patent/US746749A/en
Application granted granted Critical
Publication of US746749A publication Critical patent/US746749A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose

Definitions

  • My present invention does not contemplate a radical reconstruction of the constituent elements of devices of this character, but rather the adaptation of old principles with the -mechanical elements reduced to their simplest proposition and as a natural sequence accentuating the utilitarian residual benefits thereof and adapting them to subserve the highest economic ends.
  • the object of my invention is the provision of a syringe, insufflator, atomizer, sprayer, injector, or inhaler consisting of a mechanical composite of tested instrumentalities or concatenations or tantamount devices for directing a medicament into or upon the nasal passages and organs and the plexus constituting the respiratory system.
  • Another object'of my invention is the pro vision of a nasal medicator consisting of simple mechanical propositions correlated into a usonant ensemble for the expeditious insertion of aeriform or gaseous medicants to the pituitary or mucous membrane,the meatuses, the ramifications of the olfactory nerves, and contiguous and sympathetic organs thereof.
  • Another object is the provision of a mer cable nasal medicator apposite to the ampliably subserving the highest economic ends as a natural sequence to the germanic synthesis of the mechanical construction and the intermutuality of utilization.
  • Still another object is the provision of a nasal medicator for the insertion of medicaments or douches of either a'liquid, powder, or gaseous constituent into the nasal passages for the purpose of a douche, equration,
  • a nasal medicator consisting of a minim nm of mechanical parts adapted to obtain a maximum ofefficiency and which can be manufactured and sold at a comparatively low price.
  • my invention consists in the form, construction, and arrangement of the several elements with reference to each other and'the specific attachments with the interstinctive parts intermutually combined and in the legitimate combinations of the several parts with reference to each other and to the entire invention.
  • Figure 1 is an isometrical view of my entire invention, showing one manner of application.
  • Fig. 2 is a central longitudinal section of same.
  • Fig. 3 is a modified form of my invention, showing a diiferent manner of application and use.
  • indice A represents the mouth, and B the nose, of anindividual.
  • the indice 0 represents a receptacle which I design shall contain a medicamentsuch, for instance, as a menthol or the like.
  • the indice D represents the upper converging end of the receptacle 0, which is adapted for insertion in the nostrils of the patient.
  • the lower end of the receptacle C is formed open, with a bushing or gasket E, formed of cork or soft rubber, adapted to fit therein, and a central opening is provided through the bushing E to receive and hold the large end of the fitting G.
  • the fitting G is preferably tral opening therethrough of same general contour thereof.
  • the large end of said fitting is adapted to be inserted in the opening formed U-shaped, with a cenin the bushing E and the opposite or small end to receive the lower end of the flexible tube H.
  • a mouthpiece I In the upper end of the flexible tube H is inserted a mouthpiece I, with a central opening therethrough.
  • F represents a medicament contained in the receptacle, and it should be of a porous or granular formation in order that it may be penetrated by a forced draft
  • K and L represent the upper and lower dams, respectively, to retain the medicamentin place. Small openings are formed through the said dams in an axial direction to allow the air to pass through the space inclosed thereby.
  • menthol-is placed in the receptacle 0 and secured between and by the dams K and L, and the parts of the invention are otherwise assembled substantially as shown in Fig. 2.
  • the point D is then placed to or in one of the nostrils of the nose B, and the mouthpiece I is placed between the lips of the mouth A, and the air is then exhaled from the lungs through the opening in the mouthpiece I, the flexible tube H, the fitting G into the interior of the receptacle 0, where the air becomes charged with the medicament in its passage therethrough and is forced through the nostril and the meatuses to the pituitary or mucous membrane, where the medicament is desired to be effective and which by the ordinary method of inhaling the medicated air would pass beyond said parts and enter the lungs of the patient.
  • the fitting G instead of being U-shaped, as shown, may, if desired, be made L-shaped, only requiring a small additional length of the tube H, but making the fitting more easy of manufacture.
  • a nasal medicator In a nasal medicator, the combination, a medicament-receptacle provided with an upper converging end and a lower open end, a bushing fitted in the lower end of the receptacle, a U-shaped fitting with an opening therethrough, one end of said fitting being inserted in the opening in bushing and the other end of the fitting being inserted into the lower end of a flexible tube, the flexible tube connected to said fitting and to a mouthpiece, the mouthpiece connected to the'upper end of said flexible tube with a central opening IIO connecting therewith, a pair of perforated

Description

. tude of its various requirements, incontest- UNITED STATES GEORGE E. SEIDEL, OF
NASAL ME iatented December 15, 1903.
RIOHMOND, INDIANA.
DICATOR.
SPECIFICATION forming part of Letters Patent No. 746,749, dated December 1903- Application filed March 18, 1903.
To aZZ whom it may concern:
Be it known that I, GEORGE E. SEIDEL, a citizen of the United States, residing in the city of Richmond, in the county of VV-ayne and State of Indiana, have invented certain new and useful Im provemeuts-in Nasal Medicators, of which the following is a specification, which when taken in connection with the accompanying drawings, forming a part thereof,is sufiiciently clear and concise as to enable others skilled in the art to which it appertains to make and use the same in its preferred and modified construction.
My present invention does not contemplate a radical reconstruction of the constituent elements of devices of this character, but rather the adaptation of old principles with the -mechanical elements reduced to their simplest proposition and as a natural sequence accentuating the utilitarian residual benefits thereof and adapting them to subserve the highest economic ends.
The object of my invention, broadly speaking, is the provision of a syringe, insufflator, atomizer, sprayer, injector, or inhaler consisting of a mechanical composite of tested instrumentalities or concatenations or tantamount devices for directing a medicament into or upon the nasal passages and organs and the plexus constituting the respiratory system.
Another object'of my invention is the pro vision of a nasal medicator consisting of simple mechanical propositions correlated into a usonant ensemble for the expeditious insertion of aeriform or gaseous medicants to the pituitary or mucous membrane,the meatuses, the ramifications of the olfactory nerves, and contiguous and sympathetic organs thereof.
Another object is the provision of a mer cable nasal medicator apposite to the ampliably subserving the highest economic ends as a natural sequence to the germanic synthesis of the mechanical construction and the intermutuality of utilization.
Still another object is the provision of a nasal medicator for the insertion of medicaments or douches of either a'liquid, powder, or gaseous constituent into the nasal passages for the purpose of a douche, equration,
Serial No. 148,284. i140 model.)
ormedicament; and, finally, another object is the provision of a new article of manufacture,
a nasal medicator consisting of a minim nm of mechanical parts adapted to obtain a maximum ofefficiency and which can be manufactured and sold at a comparatively low price.
Other objects and advantages of my invention will appear from the drawings, from the description set forth otherwheres in this specification, and from the claim hereunto appended.
With the above-named objects in View my invention consists in the form, construction, and arrangement of the several elements with reference to each other and'the specific attachments with the interstinctive parts intermutually combined and in the legitimate combinations of the several parts with reference to each other and to the entire invention.
Referring now to the drawings by the indicated figures, Figure 1 is an isometrical view of my entire invention, showing one manner of application. Fig. 2 is a central longitudinal section of same. Fig. 3 is a modified form of my invention, showing a diiferent manner of application and use.
In the drawings similar indices refer to and denote similar parts throughout the several views.
I will now describe my invention in detail, which I will state as briefly and compact-1y as I may.
In the drawings the indice A represents the mouth, and B the nose, of anindividual.
The indice 0 represents a receptacle which I design shall contain a medicamentsuch, for instance, as a menthol or the like.
The indice D represents the upper converging end of the receptacle 0, which is adapted for insertion in the nostrils of the patient. The lower end of the receptacle C is formed open, with a bushing or gasket E, formed of cork or soft rubber, adapted to fit therein, and a central opening is provided through the bushing E to receive and hold the large end of the fitting G. The fitting G is preferably tral opening therethrough of same general contour thereof. The large end of said fitting is adapted to be inserted in the opening formed U-shaped, with a cenin the bushing E and the opposite or small end to receive the lower end of the flexible tube H. In the upper end of the flexible tube H is inserted a mouthpiece I, with a central opening therethrough.
F represents a medicament contained in the receptacle, and it should be of a porous or granular formation in order that it may be penetrated by a forced draft, and K and L represent the upper and lower dams, respectively, to retain the medicamentin place. Small openings are formed through the said dams in an axial direction to allow the air to pass through the space inclosed thereby.
For use the medicament-such,forinstance,
as menthol-is placed in the receptacle 0 and secured between and by the dams K and L, and the parts of the invention are otherwise assembled substantially as shown in Fig. 2. The point D is then placed to or in one of the nostrils of the nose B, and the mouthpiece I is placed between the lips of the mouth A, and the air is then exhaled from the lungs through the opening in the mouthpiece I, the flexible tube H, the fitting G into the interior of the receptacle 0, where the air becomes charged with the medicament in its passage therethrough and is forced through the nostril and the meatuses to the pituitary or mucous membrane, where the medicament is desired to be effective and which by the ordinary method of inhaling the medicated air would pass beyond said parts and enter the lungs of the patient.
In some instances I find it advisable to modify my device to a construction on the on der of a medicinal insufiiator or atomizer, in which case I replace the U-shaped fitting G with a straight or L-shaped fitting M, thus extending the flexible tube H below and parallel with the receptacle 0, as shown in Fig. 3, and to the lower end of the tube H, I secure the fitting P, providing means whereby a rubber ball 0 may be connected thereto, and on the opposite side of the ball 0 is a valve N, connected with the interior of the ball. By this modified arrangement it will beapparent that air may be pumped into the receptacle 0 by alternately contacting and releasing the ball 0, drawing the air in through the valve N, and forcing it through the medicament and thence into the nostrils and accomplishing mechanically the same results as hereinbefore stated in regard to the method of application.
It is apparent that the fitting G instead of being U-shaped, as shown, may, if desired, be made L-shaped, only requiring a small additional length of the tube H, but making the fitting more easy of manufacture.
By the use of my improved construction, substantially as herein shown and described, I have indubitably produced a device of simple construction and when expeditiously applied with the medical ingredients will accelerate the cure of the nasal and its sympathetic organs.
The simplicity of my invention, together with its positiveness of action and elfect-iveness of the resultant operation, will appeal to any one familiar with the treatment of nasal and kindred diseases, and while I am aware that devices of a somewhat similar character have been constructed, yet in my opinion they all, more or less, lack that positiveness of action and adaptation and intermutual relationship of the several elements which should be a vital characteristic of devices of this kind, and, in my opinion, the crux of the whole matter lies'more particularly in what has been the inability heretofore of conducting the medicament to the exact spot to be treated and to allow the flow to be controlled instantly at the will of the patient. This I have accomplished in the construction herein shown and described.
My invention is perfectly adapted to accomplish the results for which it is intended, and it is evident that changes in and modifications of the specific construction herein shown and described may be made and that analogous parts may be used to accomplish the same results without departing from the spirit of my invention or sacrificing any of its many advantages, and the specific construction of the details of my invention, in which novel features are embodied, may be variously changed without altering the essential principles of the invention which are claimed as new.
Having now fully shown and described my invention and the best means for. its construction and operation to me known at this time, what I claim as new, and desire to secure by Letters Patent of the United States, 1s
In a nasal medicator, the combination, a medicament-receptacle provided with an upper converging end and a lower open end, a bushing fitted in the lower end of the receptacle, a U-shaped fitting with an opening therethrough, one end of said fitting being inserted in the opening in bushing and the other end of the fitting being inserted into the lower end of a flexible tube, the flexible tube connected to said fitting and to a mouthpiece, the mouthpiece connected to the'upper end of said flexible tube with a central opening IIO connecting therewith, a pair of perforated
US14828403A 1903-03-18 1903-03-18 Nasal medicator. Expired - Lifetime US746749A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14828403A US746749A (en) 1903-03-18 1903-03-18 Nasal medicator.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14828403A US746749A (en) 1903-03-18 1903-03-18 Nasal medicator.

Publications (1)

Publication Number Publication Date
US746749A true US746749A (en) 1903-12-15

Family

ID=2815244

Family Applications (1)

Application Number Title Priority Date Filing Date
US14828403A Expired - Lifetime US746749A (en) 1903-03-18 1903-03-18 Nasal medicator.

Country Status (1)

Country Link
US (1) US746749A (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2818068A (en) * 1955-09-02 1957-12-31 Felice Anthony De Air pressure eye cup
US5906198A (en) * 1996-07-16 1999-05-25 Flickinger; William J. Nasal nebulizer
US6648848B1 (en) * 1997-05-27 2003-11-18 Direct-Haler A/S Inhaler for powdered medicaments
US20040182388A1 (en) * 1999-03-03 2004-09-23 Djupesland Per Gisle Nasal delivery method
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
GB2444395A (en) * 2006-11-28 2008-06-04 Optinose As Nasal delivery devices
GB2468794A (en) * 2006-11-28 2010-09-22 Optinose As Nasal delivery devices
US20120006323A1 (en) * 2001-06-12 2012-01-12 Optinose As Nasal devices
WO2013124492A1 (en) * 2012-02-24 2013-08-29 Optinose As Nasal delivery devices
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
US9522243B2 (en) 2002-07-02 2016-12-20 Optinose As Nasal devices
US9566402B2 (en) 2003-05-20 2017-02-14 Optinose As Delivery Device and Method
US9649456B2 (en) 2007-04-05 2017-05-16 Optinose As Nasal administration
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
US10076615B2 (en) 2007-04-05 2018-09-18 Optinose As Nasal delivery
US10112021B2 (en) 2006-06-08 2018-10-30 Optinose As Intranasal administration
US10124132B2 (en) 2006-03-06 2018-11-13 Optinose As Nasal delivery
US10179216B2 (en) 2012-02-24 2019-01-15 Optinose As Nasal delivery devices
US10252010B2 (en) 2007-10-03 2019-04-09 Optinose As Nasal delivery devices
US10300229B2 (en) 2012-02-24 2019-05-28 Optinose As Nasal delivery devices
US10398859B2 (en) 2004-09-15 2019-09-03 Optinose As Nasal delivery devices
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
US10525218B2 (en) 2006-11-28 2020-01-07 Optinose As Nasal delivery devices
US10639438B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10682331B2 (en) 2012-02-24 2020-06-16 Nasoneb, Inc. Nasal drug delivery and method of making same
US10765829B2 (en) 2006-07-25 2020-09-08 Optinose As Delivery of gases to the nasal airway
US10864334B2 (en) 2006-03-23 2020-12-15 Optinose As Nasal delivery
US10940277B2 (en) 2014-11-19 2021-03-09 Optinose As Intranasal administration
US11291626B2 (en) 2010-09-14 2022-04-05 Optinose As Nasal delivery of oxytocin
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
US11571531B2 (en) 2005-02-23 2023-02-07 OptiNose Inc. Powder delivery devices

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2818068A (en) * 1955-09-02 1957-12-31 Felice Anthony De Air pressure eye cup
US5906198A (en) * 1996-07-16 1999-05-25 Flickinger; William J. Nasal nebulizer
US6811543B2 (en) * 1997-05-27 2004-11-02 Direct-Haler A/S Method for introducing a powdered substance into a nostril
US6648848B1 (en) * 1997-05-27 2003-11-18 Direct-Haler A/S Inhaler for powdered medicaments
US20060219241A1 (en) * 1999-03-03 2006-10-05 Djupesland Per G Nasal delivery device
US20040182388A1 (en) * 1999-03-03 2004-09-23 Djupesland Per Gisle Nasal delivery method
EP1555038A3 (en) * 1999-03-03 2006-05-10 Optinose AS Nasal delivery device
US20060219240A1 (en) * 1999-03-03 2006-10-05 Djupesland Per G Nasal delivery device
US8555878B2 (en) 1999-03-03 2013-10-15 Optinose As Nasal delivery device
US20060225732A1 (en) * 1999-03-03 2006-10-12 Djupesland Per G Nasal delivery device
US20060231094A1 (en) * 1999-03-03 2006-10-19 Djupesland Per G Nasal delivery device
EP1555038A2 (en) 1999-03-03 2005-07-20 Optinose AS Nasal delivery device
US8327844B2 (en) * 1999-03-03 2012-12-11 Optinose As Nasal delivery method
US8555877B2 (en) 1999-03-03 2013-10-15 Optinose As Nasal delivery device
US9119932B2 (en) 1999-03-03 2015-09-01 Optinose As Nasal delivery device
US9072857B2 (en) 1999-03-03 2015-07-07 Optinose As Nasal delivery device
US9205208B2 (en) * 2001-06-12 2015-12-08 Optinose As Nasal devices
US20120006323A1 (en) * 2001-06-12 2012-01-12 Optinose As Nasal devices
US9522243B2 (en) 2002-07-02 2016-12-20 Optinose As Nasal devices
US9566402B2 (en) 2003-05-20 2017-02-14 Optinose As Delivery Device and Method
US10286164B2 (en) 2003-05-20 2019-05-14 Optinose As Delivery device and method
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
US20070125371A1 (en) * 2003-08-28 2007-06-07 Optinose As Delivery devices
US8800555B2 (en) * 2003-08-28 2014-08-12 Optinose As Delivery devices
US10737045B2 (en) 2003-08-28 2020-08-11 Optinose As Delivery devices
US10398859B2 (en) 2004-09-15 2019-09-03 Optinose As Nasal delivery devices
US11571531B2 (en) 2005-02-23 2023-02-07 OptiNose Inc. Powder delivery devices
US10478574B2 (en) 2006-01-19 2019-11-19 Optinose As Nasal administration
US10124132B2 (en) 2006-03-06 2018-11-13 Optinose As Nasal delivery
US10864334B2 (en) 2006-03-23 2020-12-15 Optinose As Nasal delivery
US10112021B2 (en) 2006-06-08 2018-10-30 Optinose As Intranasal administration
US10765829B2 (en) 2006-07-25 2020-09-08 Optinose As Delivery of gases to the nasal airway
US11690969B2 (en) 2006-07-25 2023-07-04 OptiNose Inc. Delivery of gases to the nasal airway
US20110126830A1 (en) * 2006-11-28 2011-06-02 Optinose As Delivery devices
GB2444395A (en) * 2006-11-28 2008-06-04 Optinose As Nasal delivery devices
US10639437B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10639438B2 (en) 2006-11-28 2020-05-05 Optinose As Delivery devices
US10525218B2 (en) 2006-11-28 2020-01-07 Optinose As Nasal delivery devices
GB2444395B (en) * 2006-11-28 2009-12-09 Optinose As Delivery devices
GB2468794A (en) * 2006-11-28 2010-09-22 Optinose As Nasal delivery devices
US9038630B2 (en) 2006-11-28 2015-05-26 Optinose As Delivery devices
GB2468794B (en) * 2006-11-28 2011-07-13 Optinose As Delivery devices
US9649456B2 (en) 2007-04-05 2017-05-16 Optinose As Nasal administration
US10722667B2 (en) 2007-04-05 2020-07-28 Optinose As Nasal administration
US10076615B2 (en) 2007-04-05 2018-09-18 Optinose As Nasal delivery
US10252010B2 (en) 2007-10-03 2019-04-09 Optinose As Nasal delivery devices
US11602603B2 (en) 2007-10-03 2023-03-14 Optinose, Inc. Nasal delivery devices
US11083858B2 (en) 2007-10-03 2021-08-10 Optinose As Nasal delivery devices
US11291626B2 (en) 2010-09-14 2022-04-05 Optinose As Nasal delivery of oxytocin
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
RU2644269C2 (en) * 2012-02-24 2018-02-08 Оптиноуз Ас Nasal substance delivery device
US10179216B2 (en) 2012-02-24 2019-01-15 Optinose As Nasal delivery devices
US10682331B2 (en) 2012-02-24 2020-06-16 Nasoneb, Inc. Nasal drug delivery and method of making same
US20150013677A1 (en) * 2012-02-24 2015-01-15 Optinose As Nasal Delivery Devices
WO2013124492A1 (en) * 2012-02-24 2013-08-29 Optinose As Nasal delivery devices
US10300229B2 (en) 2012-02-24 2019-05-28 Optinose As Nasal delivery devices
JP2015507990A (en) * 2012-02-24 2015-03-16 オプティノーズ アズ Nasal delivery device
US11033696B2 (en) 2012-02-24 2021-06-15 Optinose As Nasal delivery devices
US20220152324A1 (en) * 2012-02-24 2022-05-19 Optinose As Nasal delivery devices
US10076614B2 (en) * 2012-02-24 2018-09-18 Optinose As Nasal delivery devices
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
USD773644S1 (en) 2013-05-23 2016-12-06 Optinose As Nosepiece unit
USD809128S1 (en) 2013-05-23 2018-01-30 Optinose As Nosepiece unit
US11052204B2 (en) 2014-11-19 2021-07-06 Optinose As Intranasal administration
US10940277B2 (en) 2014-11-19 2021-03-09 Optinose As Intranasal administration
US11707586B2 (en) 2014-11-19 2023-07-25 OptiNose Inc. Intranasal administration
US11730904B2 (en) 2014-11-19 2023-08-22 Optinose, Inc. Intranasal administration

Similar Documents

Publication Publication Date Title
US746749A (en) Nasal medicator.
US4261354A (en) Inhalator-breathing apparatus
US781516A (en) Respirator and inhaler.
US605436A (en) Inhaler
US9949923B2 (en) Nasal delivery
US4262666A (en) Inhalator-breathing apparatus
EP1818070A3 (en) Inhalation therapy device for use with premature babies and infants
IE54497B1 (en) Gas induction device
US419942A (en) Insufflator
JP2017506112A (en) Continuous positive pressure device
WO2004028607A1 (en) Drug nebulizer usable with a diagnostic or therapeutic instrument, such as a bronchoscope
US1155608A (en) Inhaler.
WO2015158314A2 (en) T-device with one-way valve, flow-occlusion/release system, and pressure -release valve
US1105934A (en) Inhaler.
US533127A (en) Inhaler and respirator
US831004A (en) Inhaler.
US382113A (en) Inhaler
US330970A (en) Cliffoed
US753133A (en) Inhaler
US780077A (en) Medical vaporizer.
US429321A (en) Inhaler
RU2667819C1 (en) Method of aerosol therapy of rinosinusitis
CN112543962A (en) Device for speech therapy, administration of inhaled medicaments and for the treatment of otitis, sinusitis and barotrauma
US196812A (en) Improvement in inhalers
US1091362A (en) Inhaler.